Results 91 to 100 of about 16,295 (220)

Two bovine hepacivirus genome sequences from U.S. cattle. [PDF]

J Vet Diagn Invest
Bovine hepacivirus (BoHV) is closely related to the hepatitis C virus (HCV) in humans and can cause both acute and chronic liver infections in cattle. BoHV was first identified in Ghana and Germany in 2015 and since then it has been detected and characterized in other countries around the world, but no strains have been sequenced from U.S. cattle.
Workman AM, Harhay GP, Groves JT, Vander Ley BL.   +3 more
europepmc   +3 more sources

Hepatoma cell density promotes claudin-1 and scavenger receptor BI expression and hepatitis C virus internalization. [PDF]

, 2009
Hepatitis C virus (HCV) entry occurs via a pH- and clathrin-dependent endocytic pathway and requires a number of cellular factors, including CD81, the tight-junction proteins claudin 1 (CLDN1) and occludin, and scavenger receptor class B member I (SR-BI).
Balfe, Peter, Grove, Joe, Hu, Ke, McKeating, Jane A, Mee, Christopher J, Schwarz, Anne K   +5 more
core   +2 more sources

Hepatitis C in North Africa: A Comprehensive Review of Epidemiology, Genotypic Diversity, and Hepatocellular Carcinoma

Advances in Virology, Volume 2025, Issue 1, 2025.
Hepatitis C virus (HCV) is implicated in carcinogenic infections like hepatocellular carcinoma (HCC). Given that no HCV vaccine is currently available, comprehensive epidemiological understanding is crucial for devising effective prevention strategies.
Samia Boukaira, Salma Madihi, Hind Bouafi, Zineb Rchiad, Bouchra Belkadi, Abdelouaheb Benani, Ahmed Majeed Al-Shammari   +6 more
wiley   +1 more source

Final Report of Unmet Needs of Interferon-Based Therapy for Chronic Hepatitis C in Korea: Basis for Moving into the Direct-Acting Antiviral Era

Gut and Liver, 2017
Background/AimsTo evaluate the era of direct acting antivirals (DAAs), we must understand the treatment patterns and outcomes of interferon-based therapy for hepatitis C virus (HCV) infection.
Eun Sun Jang, Young Seok Kim, Kyung-Ah Kim, Youn Jae Lee, Woo Jin Chung, In Hee Kim, Byung Seok Lee, Sook-Hyang Jeong   +7 more
doaj   +1 more source

Evaluation of ribavirin efficacy and tolerance in subjects with chronic hepatitis C virus infection [PDF]

Vojnosanitetski Pregled, 2002
Background. Reports by hepatologists indicated that anti-HCV antibodies might be detected in 71% to 84% of cases of post-transfusion hepatitis and in up to 50% of cases of sporadic non-A non-B hepatitis.
Stanimirović Violeta, Nikolić Dejan, Stanimirović Branko, Nikolić Aleksandra, Čučak Spomenka   +4 more
doaj   +1 more source

Seroepidemiology of non-primate hepacivirus (NPHV) in Japanese native horses

Journal of Veterinary Medical Science, 2017
Non-primate hepacivirus (NPHV) is recently identified as a closely related homologue of hepatitis C virus. The previous studies showed a high prevalence of NPHV infection among Japanese domestic horses originated from abroad. The historical distribution of NPHV among horses in Japan, therefore, is still unknown. In this study, seroepidemiological study
Shizuka Hayashi, Tomohisa Tanaka, Kohji Moriishi, Kazuhiro Hirayama, Akio Yamada, Kozue Hotta   +5 more
openalex   +4 more sources

Reconstruction of the historic time course of blood‐borne virus contamination of clotting factor concentrates, 1974–1992

Journal of Medical Virology, Volume 96, Issue 7, July 2024.
Abstract Factor VIII and IX clotting factor concentrates manufactured from pooled plasma have been identified as potent sources of virus infection in persons with hemophilia (PWHs) in the 1970s and 1980s. To investigate the range and diversity of viruses over this period, we analysed 24 clotting factor concentrates for several blood‐borne viruses ...
C. Patrick McClure, Kai Kean, Kaitlin Reid, Richard Mayne, Michael X. Fu, Piya Rajendra, Shannah Gates, Judy Breuer, Heli Harvala, Tanya Golubchik, Alexander W. Tarr, William L. Irving, Michael Makris, Peter Simmonds   +13 more
wiley   +1 more source

Improving the safety of CAR‐T‐cell therapy: The risk and prevention of viral infection for patients with relapsed or refractory B‐cell lymphoma undergoing CAR‐T‐cell therapy

American Journal of Hematology, Volume 99, Issue 4, Page 662-678, April 2024.
Risk factors and prevention recommendations for viral infections in CAR T‐cell therapy. Abstract Chimeric antigen receptor (CAR) T‐cell therapy, an innovative immunotherapeutic against relapsed/refractory B‐cell lymphoma, faces challenges due to frequent viral infections.
Hu Qian, Xingcheng Yang, Tingting Zhang, Ping Zou, Yicheng Zhang, Weiwei Tian, Zekai Mao, Jia Wei   +7 more
wiley   +1 more source

First identification and phylogenetic analysis of equine hepacivirus in Korea

Infection, Genetics and Evolution, 2017
Non-primate hepacivirus (NPHV) corresponds a group of isolates recently characterized in horses and dogs that present similar genomic organization and are closely related to hepatitis C virus. Since canine hapacivirus, NPHV identified in dogs, was first discovered in dogs in the United States, equine hepacivirus (EqHV, NPHV identified in horses) has ...
Hyuk Moo Kwon, Hyun-Woo Moon, Haan Woo Sung, Ho-Seong Kim   +3 more
openaire   +3 more sources

Including osteoprotegerin and collagen IV in a score-based blood test for liver fibrosis increases diagnostic accuracy [PDF]

, 2013
BACKGROUND: Noninvasive methods for liver fibrosis evaluation in chronic liver diseases have been recently developed, i.e. transient elastography (Fibroscan™) and blood tests (Fibrometer®, Fibrotest®, and Hepascore®).
ANRS HCEP 23 Fibrostar Group, B. Baudin, B. Poggi, C. Housset, E. Lasnier, J. Guéchot, J.P. Zarski, L. Taibi, M. Vaubourdolle, M.C. Gelineau, N. Bosselut, N. Sturm, S. Thoret   +12 more
core   +2 more sources